Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation
Areej El‐Jawahri(Massachusetts General Hospital), Jennifer S. Temel(Harvard University), Thomas R. Spitzer(Harvard University), William F. Pirl(Johns Hopkins University), Joseph A. Greer(Harvard University), Lara Traeger(Massachusetts General Hospital), Alison M. Rhodes(Massachusetts General Hospital), Jason Telles(Harvard University), Thomas W. LeBlanc(Duke University), Stephanie S. Lee(Fred Hutch Cancer Center), Yi-Bin A. Chen(Harvard University), Steven L. McAfee(Harvard University), Harry VanDusen(Harvard University), Vicki A. Jackson(Johns Hopkins University)
Cited by 388
Related Papers
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
|New England Journal of Medicine|2008|969
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial
|Journal of Clinical Oncology|2017|834
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|415
Update on Bereavement Research: Evidence-Based Guidelines for the Diagnosis and Treatment of Complicated Bereavement
|Journal of Palliative Medicine|2006|307